HomeSNDX • NASDAQ
add
Syndax Pharmaceuticals Inc
Previous close
$20.88
Day range
$20.60 - $21.43
Year range
$8.58 - $21.43
Market cap
1.80B USD
Avg Volume
2.55M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 45.87M | 266.97% |
Operating expense | 96.92M | 0.76% |
Net income | -60.72M | 27.83% |
Net profit margin | -132.36 | 80.33% |
Earnings per share | -0.70 | 28.57% |
EBITDA | -57.42M | 35.89% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 454.17M | 11.76% |
Total assets | 551.79M | 29.59% |
Total liabilities | 436.36M | 634.88% |
Total equity | 115.43M | — |
Shares outstanding | 86.91M | — |
Price to book | 15.70 | — |
Return on assets | -25.01% | — |
Return on capital | -29.79% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -60.72M | 27.83% |
Cash from operations | -70.54M | -13.18% |
Cash from investing | 72.43M | -16.60% |
Cash from financing | 6.28M | 102.65% |
Net change in cash | 8.17M | -70.42% |
Free cash flow | -44.01M | -103.34% |
About
Founded
2005
Website
Employees
270
